Elise R A Pennings

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Epstein Barr Virus

Respiratory Failure

Ejection Fraction

Top Venues

JCO oncology practice

Blood cancer journal

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
Janneke W de Boer, Kylie Keijzer, Elise R A Pennings, Jaap A van Doesum, Anne M Spanjaart, Margot Jak, Pim G N J Mutsaers, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Lisanne V van Dijk, Marie José Kersten, Anne G H Niezink, Tom van Meerten, null null
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities. Cancers 15 (22) (2023)
Anne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers, Suzanne van Dorp, Margot Jak, Jaap A van Doesum, Janneke W de Boer, Anne G H Niezink, Milan Kos, Joost S P Vermaat, Aniko Sijs-Szabo, Marjolein W M van der Poel, Inger S Nijhof, Maria T Kuipers, Martine E D Chamuleau, Pieternella J Lugtenburg, Jeanette K Doorduijn, Yasmina I M Serroukh, Monique C Minnema, Tom van Meerten, Marie José Kersten, null null
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands. Cancers 15 (17) (2023)
Anna Sureda, Pieternella J Lugtenburg, Marie José Kersten, Marion Subklewe, Anne Spanjaart, Nirali N Shah, Lucila N Kerbauy, Clarie Roddie, Elise R A Pennings, Carolina Mahuad, Michelle Poon, Candice L Hendricks, Manali Kamdar, Caron A Jacobson
Cellular therapy in lymphoma. Hematological oncology (2023)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)